Denali Therapeutics Inc.
DNLI
$19.00
$1.166.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 848.20M | 898.95M | 817.93M | 832.33M | 836.56M |
| Total Receivables | 1.90M | 1.40M | 1.70M | 2.17M | 1.40M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 32.49M | 34.35M | 59.01M | 29.93M | 30.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 882.60M | 934.71M | 878.64M | 864.44M | 868.84M |
|
|
|||||
| Total Current Assets | 882.60M | 934.71M | 878.64M | 864.44M | 868.84M |
| Net Property, Plant & Equipment | 123.21M | 130.10M | 129.93M | 125.63M | 113.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.11M | 22.97M | 26.93M | 9.74M | 26.49M |
| Total Assets | 1.06B | 1.17B | 1.27B | 1.37B | 1.45B |
|
|
|||||
| Total Accounts Payable | 6.75M | 10.84M | 8.46M | 11.14M | 9.59M |
| Total Accrued Expenses | 51.58M | 50.07M | 54.56M | 64.91M | 53.14M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.24M | 10.29M | 11.52M | 12.03M | 8.09M |
| Total Finance Division Other Current Liabilities | 22.58M | 19.86M | 17.34M | 14.13M | 16.27M |
| Total Other Current Liabilities | 22.58M | 19.86M | 17.34M | 14.13M | 16.27M |
| Total Current Liabilities | 90.15M | 91.06M | 91.88M | 102.21M | 87.09M |
|
|
|||||
| Total Current Liabilities | 90.15M | 91.06M | 91.88M | 102.21M | 87.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 35.24M | 37.69M | 40.05M | 42.29M | 44.48M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.04M | 10.44M | 16.73M | -- | 3.94M |
| Total Liabilities | 129.42M | 139.19M | 148.66M | 144.50M | 135.52M |
|
|
|||||
| Common Stock & APIC | 2.85B | 2.82B | 2.79B | 2.77B | 2.74B |
| Retained Earnings | -1.92B | -1.80B | -1.67B | -1.54B | -1.42B |
| Treasury Stock & Other | 1.10M | 939.00K | 2.04M | 2.02M | 5.53M |
| Total Common Equity | 926.20M | 1.03B | 1.12B | 1.23B | 1.32B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 926.20M | 1.03B | 1.12B | 1.23B | 1.32B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 926.20M | 1.03B | 1.12B | 1.23B | 1.32B |
|
|
|||||